It has been recently suggested that the diagnosis of AD is more appropriate if it is made by A/T/N (amyloid/tau/neurodegeneration) classification system, which is more objective and quantitative than conventional AD diagnosis methods [35]. The gene discussed is MAPT; the disease is Alzheimer disease.